Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-08-17

FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Original Application (ScieGen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a generic sustained-release formulation of bupropion hydrochloride from ScieGen Pharmaceuticals (original application).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupropion hydrochloride sustained-release (Bupropion hydrochloride)

Snippet

ORIG AP for BUPROPION HYDROCHLORIDE (SR) (BUPROPION HYDROCHLORIDE)